NCT00172068View on ClinicalTrials.gov

Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow

PHASE2TerminatedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

November 30, 2008

Conditions
Primary Breast Cancer
Interventions
DRUG

Zoledronic acid + Calcium/Vitamin D

Trial Locations (4)

Unknown

Novartis Invstigative Site, Bielefeld

Novartis Investigative Site, Hanover

Novartis Investigative Site, München

Novartis Investigative Site, Tübingen

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY